Menu Search
Equities

Theratechnologies Inc

TQ80:FRA

Theratechnologies Inc

Actions
  • Price (EUR)1.01
  • Today's Change0.045 / 4.66%
  • Shares traded478.00
  • 1 Year change-47.12%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 20:39 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Theratechnologies Inc has grown net income from a loss of -47.24m to a smaller loss of -23.96m despite relatively flat revenues.
Gross margin75.94%
Net profit margin-8.47%
Operating margin3.48%
Return on assets-10.07%
Return on equity--
Return on investment-89.40%
More ▼

Cash flow in USDView more

In 2023, Theratechnologies Inc increased its cash reserves by 42.93%, or 10.24m. Cash Flow from Financing totalled 14.78m or 18.07% of revenues. In addition the company used 5.68m for operations while cash from investing totalled 1.11m.
Cash flow per share-0.1314
Price/Cash flow per share--
Book value per share-0.6843
Tangible book value per share-1.03
More ▼

Balance sheet in USDView more

Theratechnologies Inc has a Debt to Total Capital ratio of 164.27%.
Current ratio1.10
Quick ratio0.9963
Total debt/total equity--
Total debt/total capital1.64
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.